Last edition
News about "atherosclerotic cardiovascular disease (ASCVD)"
Arrowhead Pharma Reports Interim Data on Dual RNAi Therapy
Arrowhead Pharmaceuticals has announced interim topline clinical data for the first dual-functional RNAi therapeutic for the treatment of mixed hyperlipidemia.
Atherosclerotic Cardiovascular Disease (ASCVD) | 17/09/2026 | By News Bureau
Novo Nordisk Provides Phase 3 ZEUS Trial Update
Novo Nordisk shared an update on the phase 3 ZEUS trial evaluating patients with ASCVD, CKD and inflammation enrolled in a placebo-controlled study.
Atherosclerotic Cardiovascular Disease (ASCVD) | 03/08/2026 | By News Bureau | 411
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy